AR023151A1 - Preparado farmaceutico que contiene como principio activo, por lo menos una parte de acido acetilsalicilico - Google Patents

Preparado farmaceutico que contiene como principio activo, por lo menos una parte de acido acetilsalicilico

Info

Publication number
AR023151A1
AR023151A1 ARP000101318A ARP000101318A AR023151A1 AR 023151 A1 AR023151 A1 AR 023151A1 AR P000101318 A ARP000101318 A AR P000101318A AR P000101318 A ARP000101318 A AR P000101318A AR 023151 A1 AR023151 A1 AR 023151A1
Authority
AR
Argentina
Prior art keywords
preparation containing
pharmaceutical preparation
active principle
acid
acetilsalicilic
Prior art date
Application number
ARP000101318A
Other languages
English (en)
Spanish (es)
Original Assignee
Lohmann Therapie Syst Lts
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lohmann Therapie Syst Lts filed Critical Lohmann Therapie Syst Lts
Publication of AR023151A1 publication Critical patent/AR023151A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A61K31/612—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid
    • A61K31/616—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid by carboxylic acids, e.g. acetylsalicylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/37—Esters of carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A61K9/0058—Chewing gums

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Hematology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Diabetes (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Emergency Medicine (AREA)
  • Birds (AREA)
  • Cosmetics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ARP000101318A 1999-03-26 2000-03-24 Preparado farmaceutico que contiene como principio activo, por lo menos una parte de acido acetilsalicilico AR023151A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19913731A DE19913731A1 (de) 1999-03-26 1999-03-26 Medizinische Zubereitung, enthaltend als Wirkstoff zumindest einen Anteil von Acetylsalicylsäure

Publications (1)

Publication Number Publication Date
AR023151A1 true AR023151A1 (es) 2002-09-04

Family

ID=7902490

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP000101318A AR023151A1 (es) 1999-03-26 2000-03-24 Preparado farmaceutico que contiene como principio activo, por lo menos una parte de acido acetilsalicilico

Country Status (4)

Country Link
AR (1) AR023151A1 (de)
AU (1) AU3430600A (de)
DE (1) DE19913731A1 (de)
WO (1) WO2000057884A1 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10338544B4 (de) * 2003-08-19 2017-08-31 Janssen Pharmaceutica N.V. Buccale Formulierungen des Galanthamins und deren Anwendungen

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3485920A (en) * 1967-06-12 1969-12-23 Gen Foods Corp Analgesic compositions of aspirin and pectin
DE2501548A1 (de) * 1974-01-25 1975-07-31 Procter & Gamble Mundbehandlungsmittel
JPH07553B2 (ja) * 1985-12-09 1995-01-11 佐藤製薬株式会社 フイルム状製剤
DE3935550A1 (de) * 1989-10-25 1991-05-02 Pharmatrans Sanaq Ag Kaubare oder lutschbare arzneiform, verfahren zu ihrer herstellung und ihre verwendung
DE4102629A1 (de) * 1991-01-30 1992-08-06 Bayer Ag Pharmazeutischer kaugummi mit acetylsalicylsaeure
ATE202691T1 (de) * 1994-10-28 2001-07-15 Procter & Gamble Zusammensetzung für die stabilisation von zahnprothesen

Also Published As

Publication number Publication date
WO2000057884A1 (de) 2000-10-05
AU3430600A (en) 2000-10-16
DE19913731A1 (de) 2000-09-28

Similar Documents

Publication Publication Date Title
MXPA02012792A (es) Composicion y forma de de dosificacion para liberacion gastrica retardada de alendronato y/u otros bis-fosfonatos.
UY26977A1 (es) Compuestos de imidazol condensado con arilo o heteroarilo como agentes anti-inflamatorios y analgésicos
PT1207756E (pt) Utilizacao de espinosade ou de uma formulacao que compreende espinosade
AR240250A1 (es) Procedimiento para la preparacion de una nueva formualcion farmaceutica oral que contiene omeprazol como ingrediente activo.
NO20022058L (no) Farmasöytiske sammensetninger
CR6656A (es) Forma de dosificacion de farmacos accionada por un hidrogel
MXPA03007712A (es) Sales farmaceuticas.
ECSP034883A (es) Amidas de acidos antranilicos con cadena lateral de heteroarilsulfonilo, procedimiento para su preparacion, su empleo como medicamento o agente de diagnostico, asi como preparados farmaceuticos que las contienen
ATE353009T1 (de) Prozess zur herstellung von pharmazeutischen zusammensetzungen zur verwendung mit weichgelatine formulierungen
UY25192A1 (es) Formulación medicamentosa con liberación controlada de sustancia activa
PT1383752E (pt) 3-piperidinopropiofenonas deuteradas assim como farmacos contendo estes compostos
AR048318A1 (es) Formulaciones de matriz orales que comprenden licarbazepina
BR0014826A (pt) Imidazo-3-il-aminas bicìclicas, procedimento de sua preparação e medicamentos que as contêm
ES2119748T3 (es) Composicion farmaceutica que contiene un farmaco ligeramente soluble en agua.
AR023151A1 (es) Preparado farmaceutico que contiene como principio activo, por lo menos una parte de acido acetilsalicilico
PT1202956E (pt) Derivados terapeuticos e/ou nuricionalmente melhorados de ingredientes activos e composicoes de administracao oral contendo o mesmo
ES2182504T3 (es) Bifenilsulfonilcianamidas, procedimiento para su preparacion y su utilizacion como medicamento.
PA8496801A1 (es) Complejo farmaceutico
AR048138A1 (es) Formulacion farmaceutica de liberacion controlada
PT1242062E (pt) Gel anidro que compreende nsaid para administracao topica na cavidade oral
AR029096A1 (es) Combinacion de sustancias activas que contiene montirelina y un compuesto de efecto opioide, medicamentos y formulaciones medicamentosas que contienen dicha combinacion y su uso para la preparacion de medicamentos para tratamiento del dolor
DE50005282D1 (de) Medikament sowie aufeinander abgestimmte kombination von medikamenten
HN1999000174A (es) Formulacion medicamentosa acuisa para administracion oral.
ATE494239T1 (de) Vorrichtung zum abgeben von pharmazeutischen produkten
CU23150A3 (es) Formulacion de medicamento con liberacion controlada de sustancia activa